Healthcare -
Biotechnology - NASDAQ - US
$ 5.5
5.16 %
$ 49 M
Market Cap
-11.22
P/E
ICCC - SHORT-TERM DEBT
Short-term Debt ICCC - ImmuCell Corporation
2.07 M
LAST VALUE
50.09%
2 YEAR CAGR
9.05%
5 YEAR CAGR
26.97%
10 YEAR CAGR